{"version":"1.0","type":"link","title":"Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study.","author_name":"Kuemmel S 외","author_url":"https://prs-insight.online/author/Kuemmel%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/169933","thumbnail_width":1200,"thumbnail_height":630}